Viral Infections


General Viral Effects on the Central Nervous System

Definition

  • CNS viral infection associated with clinical or laboratory evidence of neurologic dysfunction based on viral tropism

Clinical Features

Epidemiology

  • Viruses: number one cause of encephalitis and meningitis

    • Most cases: acute, self-limited

    • Arboviruses: most common cause worldwide

  • U.S. incidence: 3.5 to 7.4 cases per 100,000 people per year

  • Specific host cell surface receptors facilitate entry

  • Routes: hematogenous (most common), retrograde neuronal migration (rabies/herpes)

    • Transient viremia seeds muscles/reticuloendothelial system

    • Secondary seeding of CNS, other organs

  • Infants, elderly most affected

  • Viral cultures: 33% to 75% are inconclusive

Presentation

  • Meningitis: leptomeningeal infection—nuchal rigidity, headache, fever, photophobia

    • Aseptic: culture negative; unknown etiology

  • Encephalitis: direct viral infection of parenchyma—neurologic deficits; altered consciousness, seizures

  • Meningoencephalitis: parenchymal, leptomeningeal infection

  • Encephalopathy: reversible or irreversible damage without inflammation

  • Myelitis: spinal cord (poliovirus)

  • Radiculitis: dorsal nerve roots

  • Neuritis: peripheral nerves

  • Testing

    • Most cases diagnosed by PCR, ELISA serologies of CSF and serum

    • Viral cultures

    • CSF: moderate monocytic pleocytosis, mild/moderate protein increase, normal glucose

Prognosis and Treatment

  • Most infections: self-limited; mild

  • High mortality: herpesviruses, some arboviruses

    • Neurologic sequelae common

    • Variable: based on pathogen

  • Antivirals: effective for certain pathogens

Pathology

Gross

  • Cerebral edema, vascular congestion, foci of hemorrhage

Histology

  • Nonspecific findings

    • Lymphocytic meningitis

    • Perivascular lymphocytic cuffing

    • Microglial nodules of brain parenchyma in encephalitis

    • Destruction of neurons by activated microglia (“neuronophagia”)

    • Oligodendroglial destruction can lead to demyelination

    • Ependymitis

    • Gliosis

  • Viral cytopathic effects (covered in separate chapters)

    • Intranuclear inclusions (Cowdry type A: Herpes simplex, oligodendrocytic—JC virus)

    • Cytoplasmic inclusions (Negri bodies; rabies)

Immunopathology/Special Stains

  • Pathogen-specific immunohistochemistry (IHC)

  • Immunohistochemical markers for lymphocytes, macrophages

Main Differential Diagnoses

  • Other infectious encephalitides

  • Cerebral infarct

  • Seizure disorders

  • Carcinomatosis/paraneoplastic encephalitis

  • Neurosarcoidosis

  • Thrombotic thrombocytopenic purpura (TTP)

Fig 1, Viral meningoencephalitis. An infiltrate of mononuclear cells is present within the leptomeninges and extends to involve the perivascular space of superficial blood vessels.

Fig 2, Viral meningoencephalitis. A prominent perivascular infiltrate of mature lymphocytes is shown.

Fig 3, Viral encephalitis. There is extensive parenchymal involvement by the inflammatory process with focal accumulations of mononuclear cells (microglial nodules).

Fig 4, Viral encephalitis. Microglial nodules ( upper left ) are composed of activated (rod-shaped) microglia and mononuclear cells, including lymphocytes and a few plasma cells.

Fig 5, Viral encephalitis. An immunohistochemical study for CD3 reveals perivascular and parenchymal T lymphocytes.

Fig 6, Viral encephalitis. Activated microglia develop into CD68-immunoreactive macrophages with progression of the disease.

Herpes Simplex Encephalitis

Definition

  • Acute necrotizing encephalitis caused by herpes simplex, an enveloped, double-stranded DNA virus

Clinical Features

Epidemiology

  • Most common sporadic encephalitis in the United States: two cases per million people per year

  • Neurotropic: likely spreads to leptomeninges via olfactory nerves

  • Primary infection: teens/young adults via direct contact with lesions/secretions

  • Herpes simplex virus (HSV-1): primarily oral lesions; 90% seroprevalence by age 50

    • Latency: trigeminal ganglion; occasionally cervical ganglia

    • Reactivation: occurs via anterograde axonal transport

  • HSV-2: primarily genital lesions; U.S. seroprevalence: 16% to 40%

    • Primary cause of encephalitis in neonates

    • Primary infection: up to 40%; reactivation: 8%

    • Latency: sacral dorsal root ganglia

Presentation

  • Encephalitis: acute, rapid onset with fever, altered mental status, delirium/psychiatric manifestations, seizures, neurologic deficits, smell/taste alterations, coma

    • HSV-1: primary cause

  • Less common presentations:

    • HSV-1 and -2: subacute onset; insidious encephalopathic manifestations; rarely necrotizing myelopathy

    • HSV-1: brain stem encephalitis

    • HSV-2: sacral myeloradiculitis; Mollaret's meningitis—recurrent, benign aseptic meningitis

  • CSF analysis

    • Pleocytosis (lymphocytic/monocytic), red blood cells (RBCs) elevated, glucose normal/decreased

    • PCR for HSV-1 and -2

    • Cultures usually negative

Prognosis and Treatment

  • Untreated: >70% mortality; 25% to 50% mortality with treatment

  • Sequelae common in survivors, even with appropriate treatment

    • Seizures (most common)

    • Severe neurologic deficits

    • Developmental delay

  • Treatment: acyclovir

Imaging Characteristics

  • Pathognomonic: asymmetrical increased signal intensity of bilateral temporal lobes with focal extension to adjacent frontal lobes

Pathology

Gross

  • Cerebral softening, congestion, and edema

  • Hemorrhagic necrosis of bilateral temporal lobes in asymmetrical distribution

  • Extension to posterior orbitofrontal, cingulate, insular cortex

Histology

  • Acute phase—may initially have neutrophils in subarachnoid space and brain

    • Lymphohistiocytic infiltrates in leptomeninges; perivascular spaces

    • Neuronophagia/microglial nodules

    • Classic cytopathic effect: eosinophilic Cowdry type A intranuclear inclusions (sparse)

    • Neurons and glia infected

    • Progression to geographic necrosis, focal hemorrhage, marked inflammation

  • Chronic phase (survivors)

    • Cavitary glial scar formation with atrophy, hemosiderin deposition

Immunopathology/Special Stains

  • HSV-1 and -2 immunohistochemistry

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here